A press conference highlighting the performance of the Regional Industrial Development Fund (RFRP) and the strategic scaling of enterprise investment initiatives in Tatarstan was held at the Tatmedia briefing hall. Key briefers included Rodion Karpov, First Deputy Minister of Industry and Trade of the Republic of Tatarstan; Damir Galiev, Director of the Investment and Venture Fund of the Republic of Tatarstan (IVF RT); and a corporate representative from Anatomika.

During the media briefing, Rodion Karpov highlighted the long-term impact of the Industrial Development Fund (FRP) since its inception, emphasizing its core mandate to modernize domestic manufacturing, spin up new production facilities, and deliver structural import substitution. Across its operational history in Tatarstan, the fund has financed 120 projects totaling nearly 62 billion rubles. Among the largest capital deployments are flagship projects executed by heavy-truck manufacturer KAMAZ, which secured two separate 5 billion ruble financing tranches to build an assembly line for 13 liter engines and establish domestic axle manufacturing. Karpov reiterated that accelerating industrial capacity and anchoring technological sovereignty remain top policy mandates.

Delivering the fund's operational metrics, IVF RT Director Damir Galiev reported that the fund, which has run regional FRP functions since 2016, achieved record-breaking milestones at the close of 2025. Tatarstan secured its position as the top regional fund in Russia by both deal count and total capital deployed. The record year saw eight major industrial projects fully funded for a combined 1.9 billion rubles, pulling in 1.8 billion rubles from the federal budget.

Galiev noted that amid a high central bank key interest rate environment, the RFRP offers enterprises highly competitive, insulated financing at a flat 3% annual interest rate. The fund’s current active pipeline comprises 92 projects undergoing various stages of due diligence and underwriting. The portfolio remains strictly focused on primary industrial sectors, with 53% of projects concentrated in the automotive sector and 36% in electrical equipment manufacturing.

A prime case study of this state-backed financing framework is Anatomika. Backed by joint capital from the federal FRP and IVF RT, the medical technology enterprise opened a modern 3,000 square meter manufacturing plant at the Zelenodolsk Industrial Park in 2025. The company representative showcased advanced product samples that have no domestic equivalents in Russia.

Specifically, Anatomika's external orthopedic fixation system was engineered for emergency triage and trauma response. Unlike foreign alternatives, it is optimized for field operations-offering rapid deployment and robust fracture stabilization without requiring complex surgical infrastructure. Company executives confirmed they have already captured a 2% market share in the highly competitive Russian hip endoprosthesis market. The entire manufacturing cycle is completely localized at their domestic facility, covering everything from raw materials to the finished medical devices.